Novel histone deacetylase 6 (HDAC6) selective inhibitors: a patent evaluation (WO2014181137)
Contributeurs/tricesSimoes Avello, Claudia; Bertrand, Philippe; Cuendet, Muriel
Publié dansExpert opinion on therapeutic patents, vol. 27, no. 3, p. 229-236
Date de publication2017
Résumé
Mots-clés
- Antineoplastic Agents/pharmacology
- Drug Design
- Histone Deacetylase Inhibitors/pharmacology
- Histone Deacetylases/drug effects
- Humans
- Hydroxamic Acids/pharmacology
- Neoplasms/drug therapy/pathology
- Patents as Topic
Structure d'affiliation
Citation (format ISO)
SIMOES AVELLO, Claudia, BERTRAND, Philippe, CUENDET, Muriel. Novel histone deacetylase 6 (HDAC6) selective inhibitors: a patent evaluation (WO2014181137). In: Expert opinion on therapeutic patents, 2017, vol. 27, n° 3, p. 229–236. doi: 10.1080/13543776.2017.1282945
Fichiers principaux (1)
Article (Published version)
Identifiants
- PID : unige:94969
- DOI : 10.1080/13543776.2017.1282945
- PMID : 28092474
ISSN du journal1354-3776